Pneumonitis Secondary To Combination CTla-4 And Pd-L1 Inhibitor Therapy: A Case Report

被引：0
|
作者：
Zider, A. D. [1 ]
Fried, O. [1 ]
Ruchalski, K. [1 ]
Gutierrez, A. [1 ]
Wong, D. [2 ]
Goldman, J. W. [3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Santa Monica, CA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1603
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-1/PD-L1/CTLA-4 INHIBITOR THERAPY FOLLOWING PROGRESSION ON A DIFFERENT PD-1/PD-L1 INHIBITOR: A CASE SERIES
    Mukkamala, Suresh
    Tawagi, Karine
    Matrana, Marc
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A121 - A121
  • [2] Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
    Sharma, Padmanee
    CANCER RESEARCH, 2018, 78 (13)
  • [3] PD-L1 X CTLA-4 IN INVASIVE BLADDER CANCER
    Pereira, Fabiana
    Mattos, Tatiana
    Silva, Maria Antonieta
    Martini Filho, Dino
    Fernandes, Roni
    Toledo, Luis Gustavo
    Leitao, Luiz Felipe
    Montor, Wagner
    JOURNAL OF UROLOGY, 2021, 206 : E999 - E999
  • [4] CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
    Engeland, Christine E.
    Grossardt, Christian
    Veinaide, Ruta
    Bossow, Sascha
    Lutz, Diana
    Kaufmann, Johanna K.
    Shevchenko, Ivan
    Umansky, Viktor
    Nettelbeck, Dirk M.
    Weichert, Wilko
    Jaeger, Dirk
    von Katie, Christof
    Ungerechts, Guy
    MOLECULAR THERAPY, 2014, 22 (11) : 1949 - 1959
  • [5] Cancer combination therapies by silencing of CTLA-4, PD-L1, and TIM3 in osteosarcoma
    Sorkhabi, Amin Daei
    Sarkesh, Aila
    Fotouhi, Ali
    Saeedi, Hossein
    Aghebati-Maleki, Leili
    IUBMB LIFE, 2022, 74 (09) : 908 - 917
  • [6] Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment
    Tunger, Antje
    Kiessler, Maximilian
    Wehner, Rebekka
    Temme, Achim
    Meier, Friedegund
    Bachmann, Michael
    Schmitz, Marc
    BIOMEDICINES, 2018, 6 (01)
  • [7] Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
    Zhang, Hao
    Dai, Ziyu
    Wu, Wantao
    Wang, Zeyu
    Zhang, Nan
    Zhang, Liyang
    Zeng, Wen-Jing
    Liu, Zhixiong
    Cheng, Quan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [8] Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
    Hao Zhang
    Ziyu Dai
    Wantao Wu
    Zeyu Wang
    Nan Zhang
    Liyang Zhang
    Wen-Jing Zeng
    Zhixiong Liu
    Quan Cheng
    Journal of Experimental & Clinical Cancer Research, 40
  • [9] The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix
    Mobarki, M.
    Karpathiou, G.
    Da Cruz, V.
    Chauleur, C.
    Forest, F.
    Peoc'h, M.
    VIRCHOWS ARCHIV, 2017, 471 : S80 - S80
  • [10] The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix
    Karpathiou, Georgia
    Chauleur, Celine
    Mobarki, Mousa
    Peoc'h, Michel
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (01)
12345